Total Payments
$6,777
2024 Payments
$586.08
Companies
25
Transactions
374
Medicare Patients
1,016
Medicare Billing
$77,830
Payment Breakdown by Category
Food & Beverage$6,272 (92.5%)
Education$386.73 (5.7%)
Gifts$118.80 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,272 | 361 | 92.5% |
| Education | $386.73 | 11 | 5.7% |
| Gift | $118.80 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,520 | 87 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,129 | 48 | $0 (2021) |
| Amgen Inc. | $750.46 | 47 | $0 (2024) |
| Lilly USA, LLC | $464.68 | 28 | $0 (2024) |
| Dexcom, Inc. | $420.38 | 20 | $0 (2024) |
| Abbott Laboratories | $399.89 | 22 | $0 (2024) |
| AbbVie Inc. | $374.53 | 19 | $0 (2023) |
| IBSA Pharma Inc. | $318.72 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $204.38 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $195.08 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $586.08 | 29 | Dexcom, Inc. ($138.37) |
| 2023 | $666.80 | 39 | Lilly USA, LLC ($153.30) |
| 2022 | $693.77 | 38 | Novo Nordisk Inc ($270.79) |
| 2021 | $486.48 | 31 | Novo Nordisk Inc ($173.82) |
| 2020 | $389.08 | 24 | Novo Nordisk Inc ($158.30) |
| 2019 | $1,492 | 75 | SANOFI-AVENTIS U.S. LLC ($352.79) |
| 2018 | $1,435 | 74 | SANOFI-AVENTIS U.S. LLC ($387.57) |
| 2017 | $1,028 | 64 | SANOFI-AVENTIS U.S. LLC ($357.10) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $35.70 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes Care | ||||||
| 07/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Endocrinology | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 05/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardio-renal | ||||||
| 04/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: Endocrinology | ||||||
| 03/21/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.59 | General |
| Category: Endocrinology | ||||||
| 03/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Endocrinology | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardio-renal | ||||||
| 02/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 245 | 482 | $51,605 | $20,792 |
| 2022 | 5 | 262 | 511 | $50,573 | $21,663 |
| 2021 | 6 | 265 | 413 | $45,122 | $20,062 |
| 2020 | 7 | 244 | 355 | $46,656 | $15,312 |
Total Patients
1,016
Total Services
1,761
Medicare Billing
$77,830
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 159 | $35,550 | $14,350 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 75 | $11,585 | $4,600 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 78 | 125 | $2,146 | $1,050 | 48.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 63 | $1,788 | $599.76 | 33.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 20 | 60 | $536.00 | $192.60 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 180 | $36,000 | $15,777 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 75 | $10,500 | $4,653 | 44.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 25 | 69 | $1,863 | $661.17 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 82 | 119 | $1,666 | $352.47 | 21.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 23 | 68 | $544.00 | $219.90 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 127 | $25,400 | $11,919 | 46.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 99 | $13,860 | $5,966 | 43.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 23 | $3,220 | $1,365 | 42.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 26 | 46 | $1,242 | $446.66 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 60 | 76 | $1,064 | $228.00 | 21.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 23 | 42 | $336.00 | $137.76 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 104 | $20,800 | $7,151 | 34.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 124 | $17,360 | $5,022 | 28.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 19 | $3,800 | $1,540 | 40.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 24 | $3,360 | $1,201 | 35.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 20 | 22 | $594.00 | $210.01 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 38 | 41 | $574.00 | $121.08 | 21.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 19 | 21 | $168.00 | $67.62 | 40.3% |
About Dr. Gerald Youker, MD
Dr. Gerald Youker, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912908138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Youker, MD has received a total of $6,777 in payments from pharmaceutical and medical device companies, with $586.08 received in 2024. These payments were reported across 374 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,272).
As a Medicare-enrolled provider, Youker has provided services to 1,016 Medicare beneficiaries, totaling 1,761 services with total Medicare billing of $77,830. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 08/10/2005
- Last Updated 09/22/2014
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1912908138
Products in Payments
- Ozempic (Drug) $872.14
- Repatha (Biological) $399.79
- DIABETES - DISEASE (Drug) $390.54
- PRALUENT (Drug) $368.41
- Dexcom G6 Transmitter (Medical Supply) $282.81
- Tirosint (Drug) $262.82
- Synthroid (Drug) $247.99
- FreeStyle Libre (Device) $231.36
- Victoza (Drug) $217.22
- Kerendia (Drug) $204.38
- JARDIANCE (Drug) $201.80
- FARXIGA (Drug) $183.02
- EVENITY (Biological) $178.29
- TOUJEO (Drug) $175.16
- Rybelsus (Drug) $167.20
- SOLIQUA (Drug) $149.19
- AFREZZA (Drug) $145.09
- MOUNJARO (Drug) $144.76
- Tresiba (Drug) $139.11
- TRADJENTA (Drug) $125.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
Mr. Michael Mcclung, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
Endocrinology, Diabetes & Metabolism $1.6M
James Neifing, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $475,019
Endocrinology, Diabetes & Metabolism $475,019
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Endocrinology, Diabetes & Metabolism $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Endocrinology, Diabetes & Metabolism $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Endocrinology, Diabetes & Metabolism $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307
Endocrinology, Diabetes & Metabolism $194,307